drugset / Trial / NCT05363215
A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to measure the PK, safety, and tolerability of S-217622 in participants with mild, moderate, or severe renal impairment and in those with normal renal function.
Timeline
- Start
- 2022-08-10
- Primary completion
- 2023-04-12
- Completion
- 2023-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ensitrelvir | Small molecule | — | Oral |